[
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 25412846, 25952993).",
    "cancerTypes":
    [
      {
        "id": 418,
        "subtype": "Therapy-Related Myeloid Neoplasms",
        "code": "TMN",
        "color": "LightSalmon",
        "mainType": "Leukemia",
        "level": 4,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Oncogenic Mutations",
      "name": "Oncogenic Mutations",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px1",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "25412846",
      "25952993"
    ],
    "drugAbstracts":
    []
  },
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 28819011, 26022239, 24684350, 8639789, 7579380).",
    "cancerTypes":
    [
      {
        "id": 586,
        "subtype": "Mantle Cell Lymphoma",
        "code": "MCL",
        "color": "LimeGreen",
        "mainType": "Mature B-Cell Neoplasms",
        "level": 5,
        "tissue": "Lymphoid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Oncogenic Mutations",
      "name": "Oncogenic Mutations",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px3",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "7579380",
      "28819011",
      "26022239",
      "8639789",
      "24684350"
    ],
    "drugAbstracts":
    []
  },
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 25860933, 25412851).",
    "cancerTypes":
    [
      {
        "id": 17,
        "subtype": "AML with Myelodysplasia-Related Changes",
        "code": "AMLMRC",
        "color": "LightSalmon",
        "mainType": "Leukemia",
        "level": 4,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Oncogenic Mutations",
      "name": "Oncogenic Mutations",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px1",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "25412851",
      "25860933"
    ],
    "drugAbstracts":
    []
  },
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 19188171, 20697090, 24652989, 23243274, 24004666).",
    "cancerTypes":
    [
      {
        "id": 533,
        "subtype": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
        "code": "CLLSLL",
        "color": "LimeGreen",
        "mainType": "Mature B-Cell Neoplasms",
        "level": 5,
        "tissue": "Lymphoid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Oncogenic Mutations",
      "name": "Oncogenic Mutations",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px1",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "23243274",
      "24004666",
      "20697090",
      "19188171",
      "24652989"
    ],
    "drugAbstracts":
    []
  },
  {
    "oncogenic": "Likely Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 9680348, 18337559, 17209057 Abstract: Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017. http://www.bloodjournal.org/content/128/22/3271?sso-checked=true; http://www.bloodjournal.org/content/122/21/1846).",
    "cancerTypes":
    [
      {
        "id": 645,
        "subtype": "Plasma Cell Myeloma",
        "code": "PCM",
        "color": "LimeGreen",
        "mainType": "Mature B-Cell Neoplasms",
        "level": 5,
        "tissue": "Lymphoid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Deletion",
      "name": "Deletion",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px1",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "9680348",
      "17209057",
      "18337559"
    ],
    "drugAbstracts":
    [
      {
        "link": "http://www.bloodjournal.org/content/128/22/3271?sso-checked=true",
        "abstract": "Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017"
      }
    ]
  },
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 22186996, 18596741).",
    "cancerTypes":
    [
      {
        "id": 527,
        "subtype": "Acute Myeloid Leukemia",
        "code": "AML",
        "color": "LightSalmon",
        "mainType": "Leukemia",
        "level": 3,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Oncogenic Mutations",
      "name": "Oncogenic Mutations",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px1",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "22186996",
      "18596741"
    ],
    "drugAbstracts":
    []
  },
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 22887079, 29296692, 24478400).",
    "cancerTypes":
    [
      {
        "id": 695,
        "subtype": "Essential Thrombocythemia",
        "code": "ET",
        "color": "LightSalmon",
        "mainType": "Myeloproliferative Neoplasms",
        "level": 4,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Oncogenic Mutations",
      "name": "Oncogenic Mutations",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px1",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "29296692",
      "22887079",
      "24478400"
    ],
    "drugAbstracts":
    []
  },
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 24220272, 21714648, 25092778).",
    "cancerTypes":
    [
      {
        "id": 355,
        "subtype": "Myelodysplastic Syndromes",
        "code": "MDS",
        "color": "LightSalmon",
        "mainType": "Myelodysplastic Syndromes",
        "level": 3,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Oncogenic Mutations",
      "name": "Oncogenic Mutations",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px1",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "24220272",
      "25092778",
      "21714648"
    ],
    "drugAbstracts":
    []
  },
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "PC14586 is an orally available, small-molecule structural corrector specific for the Y220C-mutant p53 protein. In a phase I study of PC14586 in 29 patients with advanced solid tumors harboring a TP53 Y220C mutation, one patient with small cell lung cancer and one patient with breast cancer each had a partial response to treatment (Abstract: Dumbrava et al. Abstract# 3003, ASCO 2022. https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.3003). In vivo xenograft studies with TP53 Y220C-mutant gastric cancer cell line NUGC3 and Y220C-mutant patient-derived xenografts demonstrated sensitivity to PC14586 treatment as measured by dose-dependent tumor shrinkage and conversion of TP53 Y220C to the wildtype conformation (Abstract: Dumble et al. Abstract# LB006, AACR 2021. https://aacrjournals.org/cancerres/article/81/13_Supplement/LB006/669897/Abstract-LB006-PC14586-The-first-orally).",
    "cancerTypes":
    [
      {
        "id": 984,
        "subtype": "",
        "code": "",
        "color": "",
        "mainType": "All Solid Tumors",
        "level": -1,
        "tissue": "",
        "tumorForm": "SOLID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "missense_variant",
        "isGenerallyTruncating": false,
        "description": "A sequence variant, that changes one or more bases, resulting in a different amino acid sequence but where the length is preserved"
      },
      "alteration": "Y220C",
      "name": "Y220C",
      "refResidues": "Y",
      "proteinStart": 220,
      "proteinEnd": 220,
      "variantResidues": "C",
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "3A",
    "fdaLevel": "Fda3",
    "drug":
    [
      "PC14586"
    ],
    "drugPmids":
    [],
    "drugAbstracts":
    [
      {
        "link": "https://aacrjournals.org/cancerres/article/81/13_Supplement/LB006/669897/Abstract-LB006-PC14586-The-first-orally",
        "abstract": "Dumble et al. Abstract# LB006, AACR 2021"
      },
      {
        "link": "https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.16_suppl.3003",
        "abstract": "Dumbrava et al. Abstract# 3003, ASCO 2022"
      }
    ]
  },
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 22887079, 25516983, 22052707).",
    "cancerTypes":
    [
      {
        "id": 632,
        "subtype": "Primary Myelofibrosis",
        "code": "PMF",
        "color": "LightSalmon",
        "mainType": "Myeloproliferative Neoplasms",
        "level": 4,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Oncogenic Mutations",
      "name": "Oncogenic Mutations",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px1",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "22887079",
      "25516983",
      "22052707"
    ],
    "drugAbstracts":
    []
  },
  {
    "oncogenic": "Oncogenic",
    "drugDescription": "This assertion is supported by (PMID: 22887079, 25516983, 22052707).",
    "cancerTypes":
    [
      {
        "id": 185,
        "subtype": "Myeloproliferative Neoplasms",
        "code": "MPN",
        "color": "LightSalmon",
        "mainType": "Myeloproliferative Neoplasms",
        "level": 3,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      }
    ],
    "excludedCancerTypes":
    [],
    "variant":
    {
      "gene":
      {
        "entrezGeneId": 7157,
        "hugoSymbol": "TP53",
        "oncogene": false,
        "grch37Isoform": "ENST00000269305",
        "grch37RefSeq": "NM_000546.5",
        "grch38Isoform": "ENST00000269305",
        "grch38RefSeq": "NM_000546.5",
        "geneAliases":
        [
          "LFS1",
          "p53"
        ],
        "genesets":
        [],
        "tsg": true
      },
      "consequence":
      {
        "term": "NA",
        "isGenerallyTruncating": false,
        "description": "NA"
      },
      "alteration": "Oncogenic Mutations",
      "name": "Oncogenic Mutations",
      "refResidues": null,
      "proteinStart": -1,
      "proteinEnd": 100000,
      "variantResidues": null,
      "referenceGenomes":
      [
        "GRCh38",
        "GRCh37"
      ]
    },
    "level": "Px1",
    "fdaLevel": null,
    "drug":
    [],
    "drugPmids":
    [
      "22887079",
      "25516983",
      "22052707"
    ],
    "drugAbstracts":
    []
  }
]
